Moreover, driver mutations including K-ras mutation, EGFR mutation, ALK rearrangement, ROS1 rearrangement, PI3K mutation et al. are almost mutually exclusive in NSCLC patients [62]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.